Goldman Sachs Upgrades Allstate (ALL) to Neutral
Get Alerts ALL Hot Sheet
Price: $173.01 +1.87%
Rating Summary:
18 Buy, 16 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
18 Buy, 16 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Goldman Sachs upgraded Allstate (NYSE: ALL) from Sell to Neutral and raised their price target from $31 to $37 following better-than-expected Q1 results and execution.
The firm comments, "We are moving to a Neutral rating on shares of Allstate and removing from the Americas Sell list, as the company appears to be able to digest higher advertising costs in Esurance through more profitable underwriting elsewhere."
Goldman raised FY12 EPS from $3.57 to $4.13, FY13 from $3.64 to $4.05 and FY14 from $3.85 to $4.35.
For an analyst ratings summary and ratings history on Allstate click here. For more ratings news on Allstate click here.
Shares of Allstate closed at $32.91 yesterday.
The firm comments, "We are moving to a Neutral rating on shares of Allstate and removing from the Americas Sell list, as the company appears to be able to digest higher advertising costs in Esurance through more profitable underwriting elsewhere."
Goldman raised FY12 EPS from $3.57 to $4.13, FY13 from $3.64 to $4.05 and FY14 from $3.85 to $4.35.
For an analyst ratings summary and ratings history on Allstate click here. For more ratings news on Allstate click here.
Shares of Allstate closed at $32.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- 29Metals Ltd (29M:AU) PT Lowered to AUD0.50 at RBC Capital
- Safran SA (SAF:FP) (SAFRY) PT Raised to EUR211 at Citi, 'remain positive on the aftermarket'
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Analyst PT Change, UpgradesRelated Entities
Goldman Sachs, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!